Opening keynote speaker Paul Workman, Institute of Cancer Research, London
The symposium was opened by keynote speaker Paul Workman, Institute of Cancer Research, London with reflections on the evolution of genomic medicine and drug development through the past 20 years. Professor Matthias Mann’s, Novo Nordisk Foundation Center for Protein Research closing keynote inspired discussions about promising new directions for integrating proteomics in the comprehensive molecular profiling of tomorrow’s patients - setting the stage for the next ten years of advancements and the future of precision medicine.
Frederik
Otzen Bagger, Department of Genomic Medicine, Rigshospitalet on challenges and
solutions in handling large-scale genomic data
The symposium showcased the power of collaboration from the multidisciplinary tumor boards to international partnerships. Thank you to all who participated and for an inspiring day boosting our motivation to “keep going” as Magnus Carlsson, former president of Swedish Sarcoma Association and patient advocate, said as Guest Speaker invited by Illumina.
Find the full program here
Read more about CoPPO
The symposium was supported by Illumina